Journal of Clinical Endocrinology & Metabolism (JCEM)
Published October 13, 2026
00:00
--:--
Effects of tirzepatide (GIP/GLP-1 dual receptor agonist) on cardiorenal biomarkers and functional...
October 14, 2026
Share
Effects of tirzepatide (GIP/GLP-1 dual receptor agonist) on cardiorenal biomarkers and functional capacity in heart failure: a systematic review and meta-analysis.
